NATHBIOGEN152.50

Nath Bio-Genes (India) Limited

· FMCG & Retail
₹ CrorePeersSARVESHWARINDOUSSUKHJITSKOHINOORAGRITECHREGAALBSHSLGULPOLYMcap ₹290 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation3.33.84.0
+ Finance Costs9.10.00.0
+ Fair Value (Gains) / Losses0.01.0-1.8
+ Undistributed Profits of Associates0.10.00.0
+ Other Non-cash Items-0.0-0.30.2
+ Other Reconciling Items0.0-0.5-0.0
Changes in Working Capital
+ Inventories-22.5-107.7-112.5
+ Trade Receivables — Current2.83.8-0.4
+ Other Financial Assets — Non-current0.01.70.0
+ Other Current Assets-3.90.025.6
+ Other Non-current Assets-1.10.01.5
+ Trade Payables — Current15.636.251.6
+ Other Financial Liabilities — Current0.0-27.90.0
+ Other Financial Liabilities — Non-current0.0-2.5-35.0
+ Other Current Liabilities-0.363.20.0
+ Other Non-current Liabilities29.30.01.4
+ Provisions — Current-3.40.03.9
+ Provisions — Non-current-0.20.5-6.0
Cash from Operating Activities
Profit Before Tax (per I/S)41.640.646.343.4
+ Total Adjustments (incl. Working Capital)28.5-28.8-67.4
Cash from Operations (pre-tax)70.011.8-21.1
+ Interest Received — Operating-0.3-3.6-6.5
+ Interest Paid — Operating0.0-10.5-16.0
+ Other Inflows / (Outflows) — Operating0.90.00.0
+ Income Taxes Paid0.31.10.9
Cash from Operating Activities70.317.6-12.6
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)8.47.93.0
+ Disp of Fixed Assets0.00.10.0
+ Disp of Intangible Assets0.00.30.1
+ Acq of Investment Property1.00.00.1
+ Loans & Advances Made18.40.00.0
+ Interest Received — Investing0.33.66.5
Cash from Investing Activities-27.4-4.03.5
Cash from Financing Activities
+ Proceeds from Borrowings-2.413.4-4.3
+ Repayment of Borrowings-3.21.2-10.1
+ Interest Paid9.110.5-16.0
+ Dividends Paid-3.83.83.8
+ Other Inflows / (Outflows) — Financing0.0-0.0-21.8
Cash from Financing Activities-4.5-2.1-3.8
Net Changes in Cash (pre-FX)38.411.5-12.9
Net Changes in Cash38.411.5-12.9
Closing Cash76.4
Reference Items
EBITDA49.949.852.449.3
EBITDA Margin %14.9913.6511.7810.07
Free Cash Flow (CFO − Capex)61.99.7-15.6-15.6
Free Cash Flow to Equity16.2-15.6
Free Cash Flow per Basic Share32.575.08-8.20-8.20
Cash Flow to Net Income1.770.46-0.30
Cash Paid for Taxes0.31.10.9
Cash Paid for Interest9.110.5-16.0
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.